Lawmakers Probe Bayer Drug-Supplement Marketing

Law360, New York (October 14, 2008, 12:00 AM EDT) -- U.S. Democratic lawmakers have furthered the probe into a Bayer AG medication that combines Aspirin with plant-based supplements and that the company claims can lower bad cholesterol.

Two Michigan Democrats — House Committee on Energy and Commerce Chairman John D. Dingell and Subcommittee on Oversight and Investigations Chairman Bart Stupak — released letters on Tuesday questioning the pharmaceutical company’s promotion of the medicine Aspirin with Heart Advantage following warnings from the U.S. Food and Drug Administration that products which combine drugs with dietary supplements may not...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.